GeneDx Holdings Corp.
corporate_fare Company Profile
GeneDx Holdings Corp. (NASDAQ:WGS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 34 items for WGS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for WGS spans 8-K, 10-Q, 4, SCHEDULE 13D/A.
Recent high-impact activity:
- GeneDx Confirms CEO Handoff: Cunningham In, Stueland Out by December 15
- GeneDx Swaps CEOs: Ex-Illumina Commercial Chief Cunningham Takes Over by December 15
- GeneDx Slides Premarket as Q4 Revenue Outlook Lands Well Below Consensus
- GeneDx 10-Q: Q3 Net Loss Widens to $12.3M, Nine-Month Operating Cash Burn Hits $72M
- GeneDx Q3 Revenue Up 5% but Adjusted Profit Halves; Guidance Trimmed
Financial Snapshot
Short Interest & Short Volume
7.27 days to coverFINRA reported short interest of 6,552,860 shares in WGS as of the October 30, 2026 settlement, a 8.8% increase from the prior period — about 7.3 days to cover at its recent average daily volume. On November 20, 2026, 64.9% of WGS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.